CytoMed Therapeutics (GDTC)

• Market cap: $9.72M
• 1 day: 2.29%
• 5 days: -10.73%
• 1 month: -15.32%
• 3 months: 13.56%
• 6 months: -23.95%
• Year to date: -40.91%
• 1 year: -55.84%
• 5 years: -79.47%
• 10 years: -79.47%
• Sector: Healthcare
• Industry: Biotechnology

About: CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Employees: 42